India's generic drug makers eye research
527105
After years of churning out cheap copycat drugs for the home market, Indian pharmaceutical firms are trying their hand at researching new drugs as they seek fresh revenue streams to cement their long-term survival.
757415
The future will bring generic competition for Lipitor's lucrative base of customers.
151995
Scientists are examining using the ancient Indian   ayurvedic medicine for use in drugs to treat Alzheimer's disease.
410178
Sept. 20, 2004 -- From patches to inhalers, drug delivery systems have come a long way. Now scientists in India are developing a new gel pill that may one day make medications work more efficiently.
158083
The FDA is investigating Teva's generic version of Wellbutrin XL.
231996
The world's leading drug companies have promised to publish more data about clinical trials into new medicines to reassure the public about their safety.
482126
J&J already has generic competition for its new drug.
734267
By Thomas Ginsberg, The Philadelphia Inquirer  Jan. 31--Here is something you may not hear every day: The drug giant Wyeth said yesterday that it was "surprised" to hear that it is about to face generic competition on its $216 million heart drug Inderal LA.
251406
LONDON - Researchers in India are testing a new way to deliver medications orally that previously had to be injected. Based on their laboratory results, the scientists say they&#39;ve created a gel that withstands the acidic environment of the stomach.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
240121
Drugmakers get part of the job done outside of the U.S.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
668287
Traditional drug companies want what biotech companies have. Will the infatuation last?
426658
Five nations launched an   initiative on Tuesday to raise at least $300 million next year   to buy generic drugs at steep volume discounts to fight AIDS,   tuberculosis and malaria in developing countries.
702018
The U.S. Federal Trade Commission asked generic drug manufacturers for prices, cost data and sales information to help study the short- and long-term effects of authorized generics on prescription drug competition, the agency said on Friday.
529230
Following an inspection by the World Health Organization (WHO), Indian generic manufacturer Hetero Drugs is withdrawing six antiretrovirals from the WHO prequalification list in order to review data on their bioequivalence.
503358
Although the volume of prescription drugs and drug ingredients coming into the country from foreign manufacturers in developing nations such as India and China has exploded in recent years, the Food and Drug Administration's budget for foreign inspections has not kept pace and will be lower in 20...